Skip to search formSkip to main contentSkip to account menu

Xamoterol

Known as: (+-)-N-(2-((2-Hydroxy-3-(p-hydroxyphenoxy)propyl)amino)ethyl)-4-morpholinecarboxamide, 4-Morpholinecarboxamide, N-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-, (+-)-, Xamoterol [Chemical/Ingredient] 
A phenoxypropanolamine derivative that is a selective beta-1-adrenergic agonist.
National Institutes of Health

Related topics

Related topics

13 relations

Broader (1)

Adrenergic beta-1 Receptor Agonists

Narrower (5)

CarwinCorwinICI-118587Xamoterol Fumarate
In Bloodagonistsanalogs & derivativesantagonists & inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Effects of long-term xamoterol therapy on the left ventricular mechanical efficiency in patients with ischemic heart disease
SummaryMyocardial oxygen uptake and an index of mechanical left ventricular efficiency were determined in basal conditions or… 
1991
1991
The Effect of the Partial Beta‐1-Adrenoceptor Agonist Xamoterol on Hemodynamics and Myocardial Energetics in Patients with Idiopathic Dilated Cardiomyopathy
Namoterol, a new partial β1-adrenacepter agonist, was evaluated in respect to its hemody namic and energetic effects when given… 
1990
1990
Xamoterol monotherapy in heart failure
The effect of xamoterol as sole therapy was investigated in randomized, double-blind, placebo-controlled studies involving 425… 
1990
1990
Effects of xamoterol on the reversible cycling of cardiac beta-adrenoceptors.
We have examined the effects of xamoterol, a partial beta 1-adrenoceptor agonist, on cardiac beta-adrenoceptors using isolated… 
1989
1989
Clinical efficacy of xamoterol, a /β1-adrenoceptor partial agonist, in mild to moderate heart failure
: The clinical efficacy of xamoterol, alpha beta 1-adrenoceptor partial agonist, was determined in a multicentre double-blind… 
1989
1989
The cardiovascular pharmacology of xamoterol, cicloprolol, prenalterol and pindolol in the anaesthetised dog.
An anaesthetised dog preparation was used to examine the pharmacological profiles of xamoterol, cicloprolol, prenalterol and… 
Review
1989
Review
1989
The Efficacy of Xamoterol in Heart Failure of Ischemic Origin
Mecanisme d'action, etude pharmacologique, et efficacite d'un traitement de l'insuffisance cardiaque due a une ischemie, par le… 
1989
1989
Xamoterol in mild to moderate heart failure: a subgroup analysis of patients with cardiomegaly but no concomitant angina pectoris. The European 'Corwin' Study Group.
Xamoterol has been shown in large, double-blind studies to produce benefit in patients with heart failure. Ischaemic heart… 
1987
1987
Hemodynamic effects ofthef31-adrenoceptor partial agonist xamoterol inrelation toplasma norepinephrine levels during exercise inpatients withleft ventricular dysfunction
A new cardioselective ,81-adrenoceptor partial agonist, xamoterol, hasbeendeveloped forthetreatment ofheart failure, especially… 
1986
1986
Effect of xamoterol, a beta 1-adrenoceptor partial agonist, on myocardial pH decreased by coronary occlusion in dogs.
The effect of xamoterol on ischemic myocardial pH was examined in dogs. Partial occlusion of the left anterior descending…